Epilogue: Lessons from the CONVERGE study of major depressive disorder in China  by Flint, Jonathan et al.
Journal of Affective Disorders 140 (2012) 1–5
Contents lists available at SciVerse ScienceDirect
Journal of Affective Disorders
j ourna l homepage: www.e lsev ie r .com/ locate / jadReview
Epilogue: Lessons from the CONVERGE study of major depressive disorder
in China
Jonathan Flint a,⁎, Yiping Chen b, Shenxun Shi c,d, Kenneth S. Kendler e
and CONVERGE consortium
a Wellcome Trust Centre for Human Genetics, Oxford OX3 7BN, UK
b Clinical Trial Service Unit, Richard Doll Building, Old Road Campus, Roosevelt Drive, Oxford OX3 7LF, UK
c Fudan University afﬁliated Huashan Hospital, No. 12 Wulumuqi Zhong Road, Shanghai 200040, PR China
d Shanghai Jiao Tong University School of Medicine afﬁliated Shanghai Mental Health Centre, No. 600 Wan Ping Nan Road, Shanghai 200030, PR China
e Virginia Commonwealth University, Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Richmond, VA 23298-0126, United Statesa r t i c l e i n f o⁎ Corresponding author.
E-mail address: jf@well.ox.ac.uk (J. Flint).
0165-0327 © 2011 Elsevier B.V.
doi:10.1016/j.jad.2011.09.006
Open access under CC BY lia b s t r a c tArticle history:
Received 15 June 2011
Received in revised form 29 June 2011
Accepted 6 September 2011
Available online 28 September 2011This review summarizes the first clinical reports from the CONVERGE consortium: China, Ox-
ford and VCU Experimental Research on Genetic Epidemiology. CONVERGE sets out to investi-
gate the nature and mode of action of the genetic and environmental risk factors for major
depressive disorder (MDD). CONVERGE aims to collect 6000 cases of recurrent MDD and
6000 controls. The consortium includes hospitals in 30 cities, all with populations exceeding
5 million, and has collected over 2000 cases and controls. High quality phenotype data on
MDD collected in China is now available to determine the source and nature of this highly het-
erogeneous condition. Analyses reported in a series of papers indicate that the clinical features
and risk factors of MDD are sufficiently similar to those in the West that we can confidently
predict that the results of subsequent analyses will be widely applicable.




AnxietyContentsRole of funding source . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
Conﬂict of interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4The six articles in this issue of the JAD, together with five
others submitted elsewhere, are the first fruits of an on-going
three year collaboration between researchers in Oxford Uni-
versity in the UK, Virginia Commonwealth University in the
US and 53 provincial mental health centers and psychiatric de-
partments of generalmedical hospitals in the People's Republic
of China. The principal aim of the CONVERGE consortium
(China, Oxford and VCU Experimental Research on Geneticcense.Epidemiology) is to investigate the nature and mode of ac-
tion of the genetic and environmental risk factors for major
depressive disorder (MDD), a disease projected to become
the second leading cause of disability worldwide (after ische-
mic heart disease) by 2020 (Alonso et al., 2004; Demyttenaere
et al., 2004;Melse et al., 2000;Michaud et al., 2001;Murray and
Lopez, 1996; Ustun et al., 2004). The high prevalence, substan-
tial economic costs and relatively ineffective performance of
current treatments (Greenberg et al., 1993; Scott et al., 2003),
mark out MDD as a research priority that demands concerted
effort from many psychiatrists on a large scale.
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MDD, a genetic approach that can interrogate the entire
human genome is attractive because it requires no prior hy-
pothesis about disease causation, other than the existence
of a genetic contribution. Studies comparing concordance
rates for MDD in monozygotic and dizygotic twins provide
convincing evidence that the condition is indeed moderately
heritable, with the best estimates of heritability of ~40%
(Kendler et al., 2006a; Sullivan et al., 2000). Genome-wide
association studies (GWAS) have now shown that it is possi-
ble to identify loci in the genome that contribute to the sus-
ceptibility to common, complex diseases, such as MDD
(Lander, 2011). The molecular characterization of loci identi-
fied for other diseases is already leading to novel insights into
etiological mechanism (Harismendy et al., 2011) andwe expect
the same to be true for depression once a sufficiently large and
well characterized sample becomes available. CONVERGE's
aim is to collect such a sample. However MDD poses a number
of difficulties that are common in psychiatry, but less so for dis-
eases that have been successfully subject to GWAS.
Multiple lines of evidence indicate that MDD is heteroge-
neous, both in its causes and in its symptomatology, and that
it arises from the action and interaction between diverse en-
vironmental and genetic factors (Winokur, 1997). Discus-
sions have gone on for over 100 years about the existence
and number of subtypes of depression, each of which may re-
flect at least partly distinct diseases, with only modestly
overlapping etiologic pathways. Environmental effects on
MDD vary in their impact and mode of action, some acting
on risk throughout the lifetime (Kendler et al., 2000a) others
with much shorter risk periods (Kendler, 1998), suggesting
that environmental factors operate via more than one path-
way. There is also evidence that environmental effects impact
differentially on different subtypes of MDD (Kendler et al.,
2007).
Heterogeneity means that discovering, and investigating,
risk factors for MDD requires a very big, well characterized
clinical sample, much bigger than any previously collected,
in which both biological and environmental effects can be
jointly studied. Obtaining a sufficiently large and well-
characterized sample is a key stumbling point in MDD re-
search. To address this challenge, researchers in Oxford and
VCU turned to their psychiatrist colleagues in China for help.
With funding first from the National Alliance for Re-
search on Schizophrenia and Depression (now The Brain
and Behavior Research Foundation) and then from theWell-
come Trust, CONVERGE grew to include hospitals in 30 cities,
all with populations exceeding 5 million. The size of the hos-
pitals, and their access to large numbers of patients, makes
CONVERGE comparable to a collaboration between clinical
services with responsibility for a population the size of
Europe.
Six design features of the CONVERGE project are worth-
while summarizing here. First, CONVERGE studies only
women because of evidence that the genetic risk factors for
MDD are not entirely the same in men and women (Kendler
et al., 2006a). Second, because of evidence that recurrence is
the best index of a high familial/genetic loading for MDD
(Sullivan et al., 2000), cases were required to have a history
of at least two MDD episodes. Third, because of the relatively
elevated base rates of MDD in the general population,controls are screened by personal interview to ensure that
they had not experienced a prior depressive episode. Fourth,
to maximize the genetic homogeneity of the sample, all four
grandparents of both cases and controls are Han Chinese.
Fifth, to reduce the probability that cases with recurrent
MDD would not go on to develop bipolar disorder (which
was an exclusion criteria in our study), a minimum age for
cases is set at 30. Sixth, to reduce the probability that controls
might go on to develop MDD, the minimum age for controls
is 40.
In its relatively brief existence, CONVERGE has devel-
oped a bilingual (Mandarin–English) computerized inter-
view, trained more than 100 doctors to conduct detailed
research interviews, and recruited a smaller team to edit
and review the data including audiotapes of all interviews.
Key to CONVERGE's success has been effective communica-
tion and an ethos of scientific commitment in which all part-
ners are equal contributors, all involved in the analysis and
publication of results. This was achieved in three ways.
First, the UK and US principal investigators travel to China
to hold week long training sessions in the use of a computer-
ized assessment system, designed in collaboration with Chi-
nese psychiatrists. So far, three such meetings have taken
place, in the cities of Shanghai, Hangzhou and Dalian, to-
gether with one refresher and problem-solving meeting in
Shanghai. Second, the UK and Chinese principal investiga-
tors regularly visit participating hospitals, to identify and
solve problems in ascertaining and assessing patients and
controls, as well as to smooth out any unexpected difficul-
ties that arise subsequent to the training sessions. Finally,
the UK and US principal investigators have run one work-
shop in the analysis and presentation of results.
The workshop was held in the seaside city of Qingdao in
the summer of 2010 with the ambitious aim of analyzing
and writing up results from the first 2000 patients and 2000
controls that CONVERGE had by that date amassed. 60 doc-
tors attended for three days. The results of their labors can
be seen in the six articles in this issue of JAD, and the five
published elsewhere. The first authors on these papers are
young Chinese psychiatrists trained within the auspices of
CONVERGE as interviewers, editors and now researchers.
The emergence of this cohort of clinician–scientists is a
major achievement of the international collaboration.
The story the articles tell is one of similarities and dissimilar-
ities betweenMDD in China and the rest of theworld. So far, our
results suggest that the former far outweigh the latter. We see
this as an important observation, and one that needs to put in
the context of the difficulties associated with researching
MDD in China. Kleinman has pointed out that “culturally
coded symptoms may confound diagnosis” (Kleinman, 2004)
and has written extensively about the difference in the ways
mood is conceptualized and expressed in the middle kingdom
(Kleinman, 1986, 2007). However, to date, no one had exam-
ined in depth the full range of clinical features and risk factors
of MDD in a large Chinese sample.
Work from the CONVERGE project now shows that the
major known risk factors for MDD operate in China just as
they do elsewhere in the world. Data about the prevalence
of stressful life events support the involvement of psychoso-
cial adversity in the etiology of MDD in China, so that stress-
ful life events have an impact comparable in magnitude to
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able to show that childhood sexual abuse substantially in-
creases the lifetime risk of developing MD with the same
kind of “dose–response” relationship seen in Western studies
(Ferguson and Mullen, 1999; Kendler et al., 2000a). Similar to
other studies in Western populations (Kendler et al., 2000b;
Oakley-Browne et al., 1995; Rey, 1995; Rodgers, 1996a,b),
high levels of a parenting style (authoritarianism) increase
the risk for MDD, again with odds ratios very similar to
those seen in a US sample (Kendler et al., 2000b).
The known biological risk factors operate just as they do in
the West. Elevated levels of the personality trait neuroticism
increase the risk for lifetime MDD. The effect of neuroticism
on MDD is remarkably consistent across different countries:
Western studies estimate the OR to be about 1.5 (Kendler et
al., 2006b). CONVERGE's estimate is slightly less: 1.37. Familial
factors are known to strongly influence the risk of developing
MDD (Bland et al., 1986; Kendler and Prescott, 1999; Kupfer
et al., 1989; Lyons et al., 1998; McGuffin et al., 1987, 1996),
and they turn out to be equally important as a risk factor for
MDD in China: CONVERGE finds that individualswith a high fa-
milial risk for MDD are characterized by severe episodes of
MDD and have an earlier age of onset.
Clinical features, too, are consistent: Patients in the
CONVERGE study with an earlier age of onset of MDD are
more likely to suffer a chronic course, have higher comor-
bidity with anxiety and be less likely to marry. All of
these features agree with findings from MDD patients
ascertained in other parts of the world (Birmaher et al.,
1996; Glied and Pine, 2002; Gollan et al., 2005; Klein et
al., 1999; Lewinsohn et al., 1994; Parker et al., 2003; Zisook
et al., 2004, 2007).
CONVERGE selected patients with recurrent MDD, usually
hospitalized, so it is perhaps not surprising that the majority
of cases have severe disease. Those with melancholia, making
up 80% of cases, have a pattern of symptom severity, episode
duration and comorbidity that echoes the extant literature
(Angst et al., 2007; Joyce et al., 2002; Kendler, 1997; Rush
and Weissenburger, 1994). Similarly, patients with dysthymia
have a clinical picture broadly consistent with what has been
seen in Western studies: greater comorbidity (Markowitz et
al., 1992) and increased rates of a family history of MDD
(Klein et al., 1988, 1995; Riso et al., 1996). CONVERGE has
also found that the clinical features of post partum depression
are very similar to those observed in the West, with a similar
prevalence rate (Lee et al., 2001; O'Hara and Swain, 1996). As
in the West, stressful life events increase the risk of post par-
tum depression (Beck, 1996), and the same social (Bolton et
al., 1998; Marks et al., 1992; O'Hara et al., 1991; Payne et al.,
2009), and personality risk factors operate (Boyce et al., 1991;
Saisto et al., 2001; Verkerk et al., 2005).
But there are dissimilarities too. Findings from CON-
VERGE are inconsistent with the simple hypothesis, from
some European and US reports, that low levels of education-
al attainment increase the risk and severity of MDD (Alonso
et al., 2004). In CONVERGE, subjects with more years of edu-
cation are more likely to have MDD. Furthermore not all risk
factors work as they do in the West. High parental protec-
tiveness, which in Western countries generally increases
the risk for MDD (Kendler et al., 2000b), is protective in
China, especially when received from the father. CONVERGEalso finds much lower levels of neuroticism in our controls
than have been typically reported in Western samples (a
mean of only 3.6, compared to European averages of 12
(Martin et al., 2000)).
This last example raises the important issue of the extent to
which we can make meaningful cross-cultural comparisons
when somuch depends on the accuracy of translation between
English and Chinese, and all results pass through a cultural fil-
ter, in which expectations and prior assumptions may not be
identical between the two cultures. As Kleinman points out,
“the concept of nonpsychotic depression is not indigenous
among ordinary Chinese” and there is not a concept of mood
disorder in traditional Chinese medicine (Kleinman, 2007).
Two important points need to be born in mind here. One
is that the instruments CONVERGE deploys are developed in
the West, so raising a question as to whether they can only
see what they were designed to see. Taking personality as an
example, the development and use of indigenous personality
inventories, such as the Chinese Personality Assessment Inven-
tory (Cheung et al., 1996), has led some to argue that a different
personality model (six-factor model) is superior to the model
commonly found in the West (five factor model) (Cheung et
al., 2001). Second, cultural variation may simply reflect meth-
odological differences between studies; personality is again a
good example (Geisinger, 1994; van de Vijver and Leung,
1997): the context in which a test is administered may bias re-
sponses. Even though subjects fill in the personality question-
naires themselves, as is done Western studies, in CONVERGE
they do so in front of a doctor. Their responses are likely affected
by the respect Chinese traditionally hold for people in authority,
such as doctors.
On the other hand, while there is an acknowledged risk
that the instruments CONVERGE uses may lead us to miss,
or worse misinterpret, clinical features, the sheer amount of
information reveals new insights and opens up new avenues
for exploration. For example CONVERGE was able to look at
the relationship between education and MDD symptoms.
This led to the surprising finding that lower educational at-
tainment is associated with more neurovegetative symptoms
and increased suicidal ideation and plans, while MDD patients
with higher educational status more frequently experience
hypersomnia and loss of interest. In short, education impacts
differentially on the symptoms of depression. The rich dataset
from CONVERGE has also allowed old ideas to be tested;
there are some examples where CONVERGE results cast new
light on received knowledge. In the work on post partum de-
pression, the resemblance in presentation and risk factors con-
tradicts an older literature that saw Chinese cultural practices
protecting women from depression in pregnancy (Pillsbury,
1978; Stern and Kruckman, 1983).
CONVERGE is still in its infancy. The papers discussed here
emerged from analysis of about one third of the projected
sample size of 12,000 (due to be completed early in 2012).
Three important lessons have already emerged. First, the clini-
cal features and risk factors of MDD are sufficiently similar to
those in the West that we can confidently predict that the re-
sults of subsequent analyses will be widely applicable. Second,
as expected, high quality phenotype data on MDD can begin to
detect the sources andnature of this highly heterogeneous con-
dition. Third, as more data accumulate we expect new insights
will emerge into psychiatry's most common disease.
4 J. Flint et al. / Journal of Affective Disorders 140 (2012) 1–5CONVERGE is an example of how assaults on common
disease require collaboration between doctors on amuch larg-
er scale than previously envisaged. This importance of size, of
having a sufficiently large sample to detect the small effects,
both genetic and environmental, is a lesson already learnt by
physicians examining the genetics and phenomenology of car-
diovascular (Newton-Cheh et al., 2009) andmetabolic diseases
(e.g. Voight et al., 2010). This lesson is if anything even more
critical in psychiatry, where the problems of heterogeneity, dis-
ease definition and etiology are so much harder. CONVERGE
has learnt that lesson and is beginning to harvest its reward.
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